Search by Drug Name or NDC

    NDC 45802-0436-01 TAZAROTENE 0.5 mg/g Details

    TAZAROTENE 0.5 mg/g

    TAZAROTENE is a TOPICAL GEL in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Padagis Israel Pharmaceuticals Ltd. The primary component is TAZAROTENE.

    Product Information

    NDC 45802-0436
    Product ID 45802-436_cb71f814-6c05-474c-8dd0-27f5398871ff
    Associated GPIs
    GCN Sequence Number 031600
    GCN Sequence Number Description tazarotene GEL (GRAM) 0.05 % TOPICAL
    HIC3 L5F
    HIC3 Description ANTIPSORIATICS AGENTS
    GCN 29221
    HICL Sequence Number 013315
    HICL Sequence Number Description TAZAROTENE
    Brand/Generic Generic
    Proprietary Name TAZAROTENE
    Proprietary Name Suffix n/a
    Non-Proprietary Name tazarotene
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form GEL
    Route TOPICAL
    Active Ingredient Strength 0.5
    Active Ingredient Units mg/g
    Substance Name TAZAROTENE
    Labeler Name Padagis Israel Pharmaceuticals Ltd
    Pharmaceutical Class Retinoid [EPC], Retinoids [CS]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA213079
    Listing Certified Through 2024-12-31

    Package

    NDC 45802-0436-01 (45802043601)

    NDC Package Code 45802-436-01
    Billing NDC 45802043601
    Package 1 TUBE in 1 CARTON (45802-436-01) / 100 g in 1 TUBE
    Marketing Start Date 2023-06-05
    NDC Exclude Flag N
    Pricing Information N/A